What is Igor Beuker's peptide forecast for 2030?

By 2030 healing peptides are legal by phone across the US, under tighter rules than the promoters expect, after the FDA's July 2026 panel recommended 6 of 7 for prescription compounding. Europe and the UK still ban them. BPC-157 gets its first 1,000-person trial or the market learns nobody will fund one, and the first peptide death lawsuit reaches a US court. The legal market outside GLP-1s and insulin is about $5 billion a year; the GLP-1 money, about $100 billion, is on my GLP-1 card.